Poseida Therapeutics Inc (PSTX)
2.73
+0.02
(+0.74%)
USD |
NASDAQ |
Nov 22, 16:00
2.86
+0.13
(+4.76%)
After-Hours: 20:00
Poseida Therapeutics Total Assets (Quarterly): 293.58M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 293.58M |
| June 30, 2024 | 298.69M |
| March 31, 2024 | 262.58M |
| December 31, 2023 | 273.88M |
| September 30, 2023 | 302.25M |
| June 30, 2023 | 281.22M |
| March 31, 2023 | 313.62M |
| December 31, 2022 | 351.84M |
| September 30, 2022 | 380.48M |
| June 30, 2022 | 205.46M |
| Date | Value |
|---|---|
| March 31, 2022 | 248.15M |
| December 31, 2021 | 269.31M |
| September 30, 2021 | 261.94M |
| June 30, 2021 | 299.11M |
| March 31, 2021 | 333.34M |
| December 31, 2020 | 371.48M |
| September 30, 2020 | 405.17M |
| June 30, 2020 | 226.35M |
| March 31, 2020 | 156.30M |
| December 31, 2019 | 147.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
147.00M
Minimum
Dec 2019
405.17M
Maximum
Sep 2020
284.09M
Average
287.40M
Median
Total Assets (Quarterly) Benchmarks
| Organogenesis Holdings Inc | 446.30M |
| MaxCyte Inc | 248.61M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 206.37M |
| Shareholders Equity (Quarterly) | 87.21M |
| Debt to Equity Ratio | 0.6755 |
| Current Ratio | 3.203 |
| Net Debt Paydown Yield | -0.04% |